Les variants du SARS-CoV-2 face au dépistage et aux vaccins

As of today, September 2021, it is very difficult to predict how the SARS-CoV-2 pandemic will develop in France and around the world. The objective of this review is to analyze recent studies concerning SARS-CoV-2, especially those looking for its origin, particularly in viruses from various bat pop...

Descripción completa

Detalles Bibliográficos
Autor principal: Rouzioux, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: l'Académie nationale de médecine. Published by Elsevier Masson SAS. 2022
Materias:
Revue Générale
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673949/
https://www.ncbi.nlm.nih.gov/pubmed/34931086
http://dx.doi.org/10.1016/j.banm.2021.12.011
_version_ 1784615546271039488
author Rouzioux, C.
author_facet Rouzioux, C.
author_sort Rouzioux, C.
collection PubMed
description As of today, September 2021, it is very difficult to predict how the SARS-CoV-2 pandemic will develop in France and around the world. The objective of this review is to analyze recent studies concerning SARS-CoV-2, especially those looking for its origin, particularly in viruses from various bat populations. The ability of variants to escape vaccine responses is a real concern, as these variants show increased pathogenicity. Screening of infected subjects and large-scale sequencing are essential tools to be strengthened, for monitoring the risk of emergence of possible new variants and for the development of the second generation vaccines.
format Online
Article
Text
id pubmed-8673949
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher l'Académie nationale de médecine. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-86739492021-12-16 Les variants du SARS-CoV-2 face au dépistage et aux vaccins Rouzioux, C. Bull Acad Natl Med Revue Générale As of today, September 2021, it is very difficult to predict how the SARS-CoV-2 pandemic will develop in France and around the world. The objective of this review is to analyze recent studies concerning SARS-CoV-2, especially those looking for its origin, particularly in viruses from various bat populations. The ability of variants to escape vaccine responses is a real concern, as these variants show increased pathogenicity. Screening of infected subjects and large-scale sequencing are essential tools to be strengthened, for monitoring the risk of emergence of possible new variants and for the development of the second generation vaccines. l'Académie nationale de médecine. Published by Elsevier Masson SAS. 2022-02 2021-12-15 /pmc/articles/PMC8673949/ /pubmed/34931086 http://dx.doi.org/10.1016/j.banm.2021.12.011 Text en © 2021 l'Académie nationale de médecine. Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Revue Générale
Rouzioux, C.
Les variants du SARS-CoV-2 face au dépistage et aux vaccins
title Les variants du SARS-CoV-2 face au dépistage et aux vaccins
title_full Les variants du SARS-CoV-2 face au dépistage et aux vaccins
title_fullStr Les variants du SARS-CoV-2 face au dépistage et aux vaccins
title_full_unstemmed Les variants du SARS-CoV-2 face au dépistage et aux vaccins
title_short Les variants du SARS-CoV-2 face au dépistage et aux vaccins
title_sort les variants du sars-cov-2 face au dépistage et aux vaccins
topic Revue Générale
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673949/
https://www.ncbi.nlm.nih.gov/pubmed/34931086
http://dx.doi.org/10.1016/j.banm.2021.12.011
work_keys_str_mv AT rouziouxc lesvariantsdusarscov2faceaudepistageetauxvaccins

Ejemplares similares